Treatment Conditioned Diffusion Neurodegenerative Progression

---
name: treatment-conditioned-diffusion-neurodegenerative-progression
description: "Treatment-Conditioned Diffusion framework for forecasting neurodegenerative disease progression via high-fidelity brain state prediction. Conditions generative process on DaTscan images and levodopa equivalent daily dose. Activation: neurodegenerative, disease progression, Parkinson, diffusion, longitudinal neuroimaging, DaTscan, treatment-conditioned."
---

# Treatment-Conditioned Diffusion for Forecasting Neurodegenerative Disease Progression

Novel diffusion framework for predicting high-fidelity future brain states in neurodegenerative disease progression (Parkinson's disease). Uses treatment-conditioned generation with Transformer encoder for pharmacological dynamics.

**arXiv**: [2605.29932](https://arxiv.org/abs/2605.29932)  
**Date**: 2026-05-28  
**Categories**: cs.LG (Machine Learning), cs.CV (Computer Vision)  
**Authors**: Danylo Boiko, Viktoriia Mishkurova

## Background

Forecasting neurodegenerative disease progression is critical for long-term planning and personalized intervention. Existing approaches:
- **Scalar clinical scores** — ignore rich structure of longitudinal neuroimaging
- **Traditional generative models** — suffer from loss of anatomical details, blurring progression patterns

**Challenge**: How to generate high-fidelity future brain states while incorporating treatment dynamics?

## Methodology

### Treatment-Conditioned Diffusion Framework

Core innovation: condition generative process on:
1. **Screening DaTscan images** — initial brain state
2. **Levodopa equivalent daily dose (LED)** — treatment trajectory over one year

### Architecture Components

#### Transformer-Based Encoder
- Represents **non-linear, time-dependent pharmacological dynamics**
- Captures treatment effects on brain state evolution
- Handles longitudinal treatment history

#### Multi-Weight Region-of-Interest Mask
- Focuses generation on **biologically critical areas**
- Different weights for different brain regions
- Optimizes anatomical fidelity in progression-sensitive zones

#### Diffusion Model
- Predicts future brain states at high fidelity
- Maintains sharp anatomical boundaries
- Generates detailed progression patterns

### Key Algorithm

```python
# Treatment-conditioned diffusion pipeline
class TreatmentConditionedDiffusion:
    def __init__(self):
        self.transformer_encoder = TransformerEncoder()  # Pharmacological dynamics
        self.diffusion_model = DiffusionModel()
        self.roi_mask = MultiWeightROI()  # Biologically critical areas
    
    def forward(self, baseline_scan, treatment_history):
        # Encode treatment dynamics
        treatment_encoding = self.transformer_encoder(treatment_history)
        
        # Condition diffusion on baseline scan + treatment
        future_scan = self.diffusion_model.generate(
            baseline_scan,
            condition=treatment_encoding,
            roi_weights=self.roi_mask
        )
        return future_scan
```

## Key Findings

### Performance Metrics
Relative to baseline:
- **14.0% lower MSE** — improved pixel-wise accuracy
- **7.2% lower MAE** — better clinical score prediction
- **4.9% higher SSIM** — preserved structural similarity

### Qualitative Results
- **Sharp anatomical boundaries** maintained in generated scans
- **Subtle progression patterns** visible (not blurred)
- **Treatment effects** accurately reflected in predictions

### Clinical Applications
1. **Personalized prognosis** — predict individual disease trajectories
2. **Treatment optimization** — simulate effects of different LED doses
3. **Long-term planning** — anticipate future brain states for intervention timing

## Applications

### Use Cases
- **Parkinson's disease progression forecasting**
- **DaTscan image generation** for future states
- **Treatment response modeling** (levodopa dose optimization)
- **Clinical decision support** — when to adjust medication

### Trigger Keywords
- Neurodegenerative disease prediction
- Parkinson's progression modeling
- Longitudinal neuroimaging
- DaTscan analysis
- Treatment-conditioned generation
- Brain state forecasting
- Diffusion models for medical imaging
- Levodopa equivalent dose

### Related Domains
- Medical imaging generation
- Disease progression modeling
- Personalized medicine
- Longitudinal analysis
- Treatment optimization

## Implementation Notes

### Data Requirements
- **Baseline DaTscan images** — SPECT/PET imaging of dopamine transporter
- **Treatment history** — LED values over time (daily doses)
- **Follow-up scans** — for training/validation

### Technical Considerations
1. **ROI mask design** — identify Parkinson's-sensitive brain regions
2. **Transformer encoder architecture** — capture temporal pharmacological dynamics
3. **Diffusion model conditioning** — integrate treatment and imaging modalities
4. **Clinical fidelity metrics** — MSE, MAE, SSIM for medical accuracy

### Pitfalls
- **Small sample sizes** — neuroimaging datasets often limited
- **Treatment variability** — patient response to LED differs
- **Scanner differences** — DaTscan protocols vary across sites
- **Time-dependent effects** — treatment dynamics non-linear
- **Anatomical fidelity** — avoiding blurring in diffusion generation

## Related Skills

- **diffusion-models-medical-imaging** — generative models for medical scans
- **neurodegenerative-disease-progression** — longitudinal disease modeling
- **transformer-longitudinal-analysis** — temporal sequence encoding
- **clinical-fidelity-metrics** — MSE/MAE/SSIM for medical accuracy
- **treatment-optimization** — pharmacological dose optimization

## References

- Paper: [arXiv:2605.29932](https://arxiv.org/abs/2605.29932)
- Categories: Machine Learning (cs.LG), Computer Vision (cs.CV)
- MSC classes: 68T07 (Machine learning), 92C55 (Medical imaging)
- ACM classes: I.2.m (Miscellaneous AI), J.3 (Life and medical sciences)